Ainara Castellanos-Rubio

Prof. Ainara Castellanos-Rubio

University of the Basque Country, UPV/EHU
+1
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Science
Verified
Journal Article
Closed access
PDF file
ACAinara Castellanos-Rubio
Ainara Castellanos-Rubio
Nora Fernandez-JimenezNora Fernandez-Jimenez
Nora Fernandez-Jimenez
RKRadomir Kratchmarov
Radomir Kratchmarov
XLXiaobing Luo
Xiaobing Luo
GBGovind Bhagat
Govind Bhagat
SGSankar Ghosh
Sankar Ghosh
Long noncoding RNAs in inflammation: Growing evidence suggests that long noncoding RNAs (lncRNAs) are important modulators of gene expression. Castellanos-Rubio et al. identified a lncRNA, lnc13, that suppresses inflammatory gene expression in macrophages (see the Perspective by Huarte). Lnc13 interacts with proteins that regulate chromatin accessibility. Stimulating macrophages with a cell wall component from bacteria decreased expression of lnc13 and increased the expression of several inflammatory genes. Decreased levels of lnc13 in intestinal tissue from individuals with celiac disease hint that lnc13 may also play a role in the pathogenesis of immune-mediated diseases. Science , this issue p. 91 ; see also p. 43

5 January 2021 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
MCMaialen Sebastia de la Cruz
Maialen Sebastia de la Cruz
IGItziar Gonzalez-Moro
Itziar Gonzalez-Moro
AOAne Olazagoitia-Garmendia
Ane Olazagoitia-Garmendia
ACAinara Castellanos-Rubio
Ainara Castellanos-Rubio
ISIzortze Santin
Izortze Santin
MRNA stability influences gene expression and translation in almost all living organisms, and the levels of mRNA molecules in the cell are determined by a balance between production and decay. Maintaining an accurate balance is crucial for the correct function of a wide variety of biological processes and to maintain an appropriate cellular homeostasis. Long non-coding RNAs (lncRNAs) have been shown to participate in the regulation of gene expression through different molecular mechanisms, including mRNA stabilization. In this review we provide an overview on the molecular mechanisms by which lncRNAs modulate mRNA stability and decay. We focus on how lncRNAs interact with RNA binding proteins and microRNAs to avoid mRNA degradation, and also on how lncRNAs modulate epitranscriptomic marks that directly impact on mRNA stability.

1 January 2009 in Autoimmunity
Verified
Journal Article
Closed access
ACAinara Castellanos-Rubio
Ainara Castellanos-Rubio
ISIzortze Santin
Izortze Santin
IIIñaki Irastorza
Iñaki Irastorza
LCLuis Castaño
Luis Castaño
JVJuan Carlos Vitoria
Juan Carlos Vitoria
JBJose Ramon Bilbao
Jose Ramon Bilbao
Celiac disease (CD) is an immunological disorder caused by intolerance to ingested gliadin and other cereal prolamins that has been included in the T(H)1-dominated group of diseases, where IL-12 induced IFNgamma is the major proinflamatory signal. Recently, another linage of T cells has been described, namely T(H)17, characterized by production of IL-17, that differentiate in response to TGFbeta and IL-6 and participate in the pathogenesis of several autoimmune diseases. Using RT-PCR analysis of gene expression, we analyzed the presence of T(H)1 (IL-12 and IFNgamma) and T(H)17 (TGFbeta, IL-6, IL-17A, IL-17F and IL-23) related cytokines in intestinal biopsies from CD patients with active disease compared to remission and from treated patients after acute, in vitro re-exposure to gliadin. Potent T(H)1 and T(H)17 responses were present in the active stage of the disease, whereas short incubation of normalized biopsies with gliadin did not increase the expression of the effector cytokines, although a tendency of upregulation for both T(H)1 and T(H)17 promoting factors was observed, suggestive of a reactivation of proinflammatory pathways. These results place CD into the group of autoimmune disorders in which T(H)17 cells also participate, although the relative importance of each T cell response and their role in the initial events of the disease need further investigation.

24 October 2013 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
Nora Fernandez-JimenezNora Fernandez-Jimenez
Nora Fernandez-Jimenez
ACAinara Castellanos-Rubio
Ainara Castellanos-Rubio
LPLeticia Plaza-Izurieta
Leticia Plaza-Izurieta
IIIñaki Irastorza
Iñaki Irastorza
XEXabier Elcoroaristizabal
Xabier Elcoroaristizabal
JBJose Ramon Bilbao
Jose Ramon Bilbao
It is known that the NFκB route is constitutively upregulated in celiac disease (CD), an immune-mediated disorder of the gut caused by intolerance to ingested gluten. Our aim was to scrutinize the expression patterns of several of the most biologically relevant components of the NFκB route in intestinal biopsies from active and treated patients and after in vitro gliadin challenge, and to assess normalization of the expression using an inhibitor of the MALT1 paracaspase. The expression of 93 NFκB genes was measured by RT-PCR in a set of uncultured active and treated CD and control biopsies, and in cultured biopsy series challenged with gliadin, the NFκB modulator, both compounds and none. Methylation of eight genes involved in NFκB signaling was analyzed by conventional pyrosequencing. Groups were compared and Pearson's correlation matrixes were constructed to check for coexpression and co-methylation. Our results confirm the upregulation of the NFκB pathway and show that constitutively altered genes usually belong to the core of the pathway and have central roles, whereas genes overexpressed only in active CD are more peripheral. Additionally, this is the first work to detect methylation level changes in celiac intestinal mucosa. Coexpression is very common in controls, whereas gliadin challenge and especially chronic inflammation present in untreated CD result in the disruption of the regulatory equilibrium. In contrast, co-methylation occurs more often in active CD. Importantly, NFκB modulation partially restores coregulation, opening the door to future therapeutic possibilities and targets.

8 March 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ACAinara Castellanos-Rubio
Ainara Castellanos-Rubio
SGSankar Ghosh
Sankar Ghosh
Immune-mediated diseases, such as celiac disease, type 1 diabetes or multiple sclerosis, are a clinically heterogeneous group of diseases that share many key genetic triggers. Although the pathogenic mechanisms responsible for the development of immune mediated disorders is not totally understood, high-throughput genomic studies, such as GWAS and Immunochip, performed in the past few years have provided intriguing hints about underlying mechanisms and pathways that lead to disease. More than a hundred gene variants associated with disease susceptibility have been identified through such studies, but the progress toward understanding the underlying mechanisms has been slow. The majority of the identified risk variants are located in non-coding regions of the genome making it difficult to assign a molecular function to the SNPs. However, recent studies have revealed that many of the non-coding regions bearing disease-associated SNPs generate long non-coding RNAs (lncRNAs). LncRNAs have been implicated in several inflammatory diseases, and many of them have been shown to function as regulators of gene expression. Many of the disease associated SNPs located in lncRNAs modify their secondary structure, or influence expression levels, thereby affecting their regulatory function, hence contributing to the development of disease.

28 May 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
ICIdoia Castellanos-Rubio
Idoia Castellanos-Rubio
IRIrati Rodrigo
Irati Rodrigo
AOAne Olazagoitia-Garmendia
Ane Olazagoitia-Garmendia
OAOihane Arriortua
Oihane Arriortua
IMIzaskun Gil de Muro
Izaskun Gil de Muro
MIMaite Insausti
Maite Insausti
Local heat generation from magnetic nanoparticles (MNPs) exposed to alternating magnetic fields can revolutionize cancer treatment. However, the application of MNPs as anticancer therapy is limited by serious drawbacks. Foremost among these are the fast uptake and biodegradation of NPs by cancer cells and the unpredictable magnetic behavior of NPs when they accumulate within cells or tissues. In fact, several studies have reported that the heating power of MNPs is severely reduced in the cellular environment, probably due to a combination of increased viscosity and strong NP agglomeration. Herein, we present an optimized protocol to coat magnetite (Fe3O4) NPs larger than 20 nm with high molecular weight PEG molecules that avoid collective coatings, prevent the formation of large clusters of NPs and keep constant their high heating performance in environments with very different ionic strengths and viscosities (distilled water, physiological solutions, agar and cell culture media). The great reproducibility and reliability of the heating capacity of this [email protected] system in such different environments has been confirmed by AC magnetometry and by more conventional calorimetric measurements. The explanation of this behavior has been shown to lie in preserving as much as possible the magnetic single domain-type behavior of nearly isolated NPs. In-vitro endocytosis experiments in colon cancer derived cell line indicate that [email protected] formulations with PEGs of higher molecular weight (20 kDa) are more resistant to endocytosis than formulations with smaller PEGs (5 kDa), showing quite large uptake mean-life ( > 5 h) in comparison with other NP systems. The in-vitro magnetic hyperthermia was performed at 21 mT and 650 kHz during one hour in a pre-endocytosis stage and complete cell death was achieved 48 h post-hyperthermia. These optimal [email protected] formulations with high resistance to endocytosis and predictable magnetic response will aid the progress and the reliability of the emerging era of theranostics.